Keywords: novadel, anxiolytic, mouth, spray, promising, pk, data

NovaDel's anxiolytic mouth spray: promising PK data

Article | 16 May 2005

Print This

The USA's NovaDel Pharma has posted strong results from a pilot pharmacokinetic trial of its proprietary lingual spray delivering Pfizer's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in